Characterization of the lipophilicity of natural and synthetic analogs of delta 9-tetrahydrocannabinol and its relationship to pharmacological potency
- PMID: 2173751
Characterization of the lipophilicity of natural and synthetic analogs of delta 9-tetrahydrocannabinol and its relationship to pharmacological potency
Abstract
delta 9-Tetrahydrocannabinol, the primary psychoactive constituent in marihuana, has been studied extensively for the last 20 years; however, the mechanisms responsible for cannabinoid activity in the central nervous system are not well understood. Although it is thought that lipophilicity plays an important role in the actions of cannabinoids, studies have not been conducted to determine whether a relationship exists between the lipophilicity and behavioral potency of cannabinoid analogs. Two procedures were used to obtain n-octanol/water partition coefficients (Po/w) of naturally occurring and synthetic cannabinoids: reverse-phase high-pressure liquid chromatographic estimation of Po/w and computer calculation of Po/w based on molecular structure. The Po/w value for delta 9-tetrahydrocannabinol obtained in this study, 9.44 x 10(6), is much greater than previously reported values obtained using shake-flask methodology, yet it is in agreement with the computer calculation based on molecular structure or molecular volume. The lipophilicity of the analogs determined in this study ranged from Po/w values of 3.92 x 10(2) to 1.93 x 10(11). All pharmacologically active cannabinoid compounds were extremely lipophilic (log Po/w values greater than 4.5). Several structural alterations were found to exert considerable influence on the lipophilicity of cannabinoid analogs. Increasing the length of the side chain in a homologous series of analogs results in an increase in lipophilicity of approximately 3-fold for each CH2 group added. Introduction of a single hydroxyl group decreased lipophilicity 3- to 40-fold, depending on the site of attachment. The behavioral potency of active analogs was not found to be correlated to lipophilicity. Therefore, data obtained in this study suggest that lipophilicity is a component, but not a primary determinant of pharmacological activity in the cannabinoids.
Similar articles
-
Modeling the cannabinoid receptor: a three-dimensional quantitative structure-activity analysis.Mol Pharmacol. 1991 Nov;40(5):656-65. Mol Pharmacol. 1991. PMID: 1944237
-
Manipulation of the tetrahydrocannabinol side chain delineates agonists, partial agonists, and antagonists.J Pharmacol Exp Ther. 1999 Sep;290(3):1065-79. J Pharmacol Exp Ther. 1999. PMID: 10454479
-
Pharmacological evaluation of agonistic and antagonistic activity of cannabinoids.NIDA Res Monogr. 1987;79:108-22. NIDA Res Monogr. 1987. PMID: 2830532
-
Cannabinoids: the separation of central from peripheral effects on a structural basis.Planta Med. 1991 Oct;57(7):S60-7. Planta Med. 1991. PMID: 1659702 Review.
-
Natural cannabinoids: templates for drug discovery.Life Sci. 2005 Dec 22;78(5):454-66. doi: 10.1016/j.lfs.2005.09.014. Epub 2005 Oct 19. Life Sci. 2005. PMID: 16242157 Review.
Cited by
-
Promising Nanocarriers to Enhance Solubility and Bioavailability of Cannabidiol for a Plethora of Therapeutic Opportunities.Molecules. 2022 Sep 17;27(18):6070. doi: 10.3390/molecules27186070. Molecules. 2022. PMID: 36144803 Free PMC article. Review.
-
Towards Better Delivery of Cannabidiol (CBD).Pharmaceuticals (Basel). 2020 Aug 28;13(9):219. doi: 10.3390/ph13090219. Pharmaceuticals (Basel). 2020. PMID: 32872355 Free PMC article. Review.
-
Implications of plasma Delta9-tetrahydrocannabinol, 11-hydroxy-THC, and 11-nor-9-carboxy-THC concentrations in chronic cannabis smokers.J Anal Toxicol. 2009 Oct;33(8):469-77. doi: 10.1093/jat/33.8.469. J Anal Toxicol. 2009. PMID: 19874654 Free PMC article.
-
Cannabidiol activates neuronal Kv7 channels.Elife. 2022 Feb 18;11:e73246. doi: 10.7554/eLife.73246. Elife. 2022. PMID: 35179483 Free PMC article.
-
Quantifying Hepatic Enzyme Kinetics of (-)-∆9-Tetrahydrocannabinol (THC) and Its Psychoactive Metabolite, 11-OH-THC, through In Vitro Modeling.Drug Metab Dispos. 2019 Jul;47(7):743-752. doi: 10.1124/dmd.119.086470. Epub 2019 May 2. Drug Metab Dispos. 2019. PMID: 31048453 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources